Introducing Artificial Intelligence and Machine Learning Tools Into the Medical Writing Workflow

Authors

  • Kyla Ross, BS, MS Nonclinical Writer, Muskegon, MI

DOI:

https://doi.org/10.55752/amwa.2024.367

Abstract

Artificial intelligence (AI) and machine learning (ML) tools have been used across all spectrums of the drug development process. The US Food and Drug Administration has accepted over 100 submissions that cite the use of AI that has assisted with clinical trial recruitment, drug discovery, and dose optimization. With these insights in mind, health authorities expect the use of AI and ML tools in regulatory processes and is working to provide meaningful oversight. In medical writing, AI and ML sources have been essential to the writing process by formatting documents, designing study protocols, analyzing manuscripts, and communicating complex scientific information to lay audiences. The technological advances of AI and ML are rapidly evolving, and there is indeed a place for such technologies in the medical writer’s resource toolbox.

Published

2024-06-13

How to Cite

1.
Ross K. Introducing Artificial Intelligence and Machine Learning Tools Into the Medical Writing Workflow. AMWA. 2024;39(2). doi:10.55752/amwa.2024.367

Issue

Section

From the Guest Editor